Any amounts payable in this agreement must be paid in $A. Any amounts requiring conversion between $A and USD (including for purposes of determining the subscription price for Parent Company common stock under clause 8.3) shall be done at the USD/AUD closing wholesale spot exchange rate published by the Australian Financial Review for the day that is 2 Business Days before the date set for calculation of the relevant amount.

Foreign Exchange Considerations. The Participant hereby acknowledges that the neither the Company nor any Subsidiary or other affiliate thereof shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the U.S. dollar that may affect the value of the Incentive Unit Equivalents granted to the Participant, or of any amounts due to the Participant. The Participant shall bear any, and all risk associated with the exchange or fluctuation of currency associated with his or her Incentive Unit Equivalents. The Participant further acknowledges that he or she may be responsible for reporting inbound transactions or fund transfers that exceed a certain amount and agrees to seek appropriate professional advice as to how the exchange control regulations apply to the Incentive Unit Equivalents and the Participant’s specific situation and understands that the relevant laws and regulations can change frequently and occasionally on a retroactive basis.

Foreign Exchange. With the exception of Co-Promotion Fees and payments from Product purchases which shall be paid in RMB, all amounts payable and all calculations under this Agreement shall be made in Dollars. Sales or costs and expenses recorded in any foreign currency shall be converted into Dollars in a manner consistent with FibroGen China’s and AstraZeneca’s customary and usual conversion procedures used to prepare such Party’s audited financial statement for external reporting purposes, provided always that such practices use a widely accepted source of published exchange rates.

Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the closing exchange rate reported in The Wall Street Journal for the last Business Day of the applicable calendar quarter.

Foreign Exchange. The rate of exchange to be used in computing the amount of Net Sales invoiced in other currencies shall be made at the [* * *].

Foreign Exchange. It shall be a term and condition of each award granted under this Sub-Plan that the Eligible Employee acknowledges that that he or she may be required to do certain acts and/or execute certain documents in connection with the grant of awards under the Plan, the purchase of shares of Common Stock under the Plan and disposing of the shares of Common Stock so purchased, including but not limited to obtaining foreign exchange approval for remittance of funds and other governmental approvals within the Republic of China. Each Eligible Employee shall pay his or her own costs and expenses with respect to any event concerning such Eligible Employee arising as a result of the Plan.

Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the rate used by Verrica in its financial reporting in accordance with Accounting Standards, as applicable.

Foreign Exchange. If any currency conversion shall be required in connection with the calculation of amounts payable hereunder, such conversion shall be made using the exchange rates reported on the ​ prior the payment due date for the purchase and sale of U.S. dollars, as reported by the Wall Street Journal. With any payment in relation to which a currency conversion is performed to calculate the amount of payment due, iTeos shall provide to [[Adimab:Organization]] a true, accurate and complete copy of the exchange rates used in such calculation. Notwithstanding anything to the contrary contained herein, in the event that iTeos and/or any Affiliate enters into a Licensee Agreement for the sales or other commercial disposition of Optioned Antibodies or Programs, for which iTeos and/or its Affiliates will be compensated on a net sales basis, then the currency conversion methodology provided for in the Section 4.12 shall be substituted and replaced with the currency conversion methodology contained in such Licensee Agreement.

Foreign Exchange. The rate of exchange to be used in computing the amount of Net Sales invoiced in other currencies shall be made at the [* * *].

Foreign Exchange. If any currency conversion will be required in connection with the calculation of amounts payable hereunder, such conversion will be made using the exchange rates reported on the fifth (5th) business day prior the payment due date for the purchase and sale of U.S. dollars, as reported by the Wall Street Journal. With any payment in relation to which a currency conversion is performed to calculate the amount of payment due, [[Alector:Organization]] will provide to [[Adimab:Organization]] a true, accurate and complete copy of the exchange rates used in such calculation.